A First-in-Human Study of a Theranostic Drug Pair for the Detection and Treatment of Pancreatic Cancer
a study on Pancreatic Cancer
Metastatic Pancreatic Cancer Locally Advanced Pancreatic Adenocarcinoma integrin PET theranostic Pancreatic Neoplasms 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G. [177Lu]Lu DOTA-ABM-5G dose escalation therapy study
Lead Scientist at UC Davis
- Julie L Sutcliffe
Professor, Hematology and Oncology. Authored (or co-authored) 56 research publications.